GlaxoSmithKline Consumer Healthcare

FDA inspection history in Aiken, South Carolina, 2015

1
Form 483

Every document, by year

  • Form 483

2015: one Form 483.

The story so far

Built from the dates and citations on the documents themselves.

  1. 2015One Form 483, at Aiken, South Carolina.

Cited most

Across all GlaxoSmithKline Consumer Healthcare observations on file

The complete GlaxoSmithKline Consumer Healthcare file.

All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.

$99

The documents one by one, while the file is prepared

See the documents

Sites

Documents

1 on file, newest first
DateDocumentPrice
2015-07-10483 Form 483$99

FEI number 1046838 · most recent document Jul 10, 2015

About GlaxoSmithKline Consumer Healthcare

How many FDA Form 483s has GlaxoSmithKline Consumer Healthcare received?

FDA Intel has 1 Form 483 on file for GlaxoSmithKline Consumer Healthcare; the most recent is dated Jul 10, 2015.

When was GlaxoSmithKline Consumer Healthcare last inspected by FDA?

The most recent FDA inspection document on file for GlaxoSmithKline Consumer Healthcare is a Form 483 dated Jul 10, 2015, for the site in Aiken, South Carolina.

What did FDA cite at GlaxoSmithKline Consumer Healthcare?

The regulations cited most in the observations on file for GlaxoSmithKline Consumer Healthcare are 21 CFR 211.142 (Warehousing procedures), 1 time; 21 CFR 211.198(b)(2) (Complaint files), 1 time; 21 CFR 211.22(d) (Responsibilities of quality control unit), 1 time.